生物文圖斯公司
US ˙ NasdaqGS ˙ US09075A1088

SecurityBVS / Bioventus Inc.
InstitutionRenaissance Technologies Llc
ManagerJames Simons
Latest Disclosed Ownership489,460 shares
Latest Disclosed Value $ 4,468,770
Renaissance Technologies Llc reports 20.43% decrease in ownership of BVS / Bioventus Inc.

On May 14, 2026 - Renaissance Technologies Llc filed a 13F-HR form disclosing ownership of 489,460 shares of Bioventus Inc. (US:BVS) valued at $4,468,770 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 615,100 shares of Bioventus Inc.. This represents a change in shares of -20.43% during the quarter. The current value of the position is $4,424,718 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F BIOVENTUS COM CL A 09075A108 489,460 -125,640 -20.43 4,469 -2.36 0.0070
2026-02-12 2025-12-31 13F BIOVENTUS COM CL A 09075A108 615,100 -196,100 -24.17 4,576 -15.67 0.0071
2025-11-13 2025-09-30 13F BIOVENTUS COM CL A 09075A108 811,200 20,382 2.58 5,427 3.65 0.0072
2025-08-13 2025-06-30 13F BIOVENTUS COM CL A 09075A108 790,818 237,318 42.88 5,235 3.38 0.0070
2025-05-14 2025-03-31 13F BIOVENTUS COM CL A 09075A108 553,500 164,800 42.40 5,065 24.09 0.0077
2025-02-13 2024-12-31 13F BIOVENTUS COM CL A 09075A108 388,700 800 0.21 4,081 -11.95 0.0060
2024-11-13 2024-09-30 13F BIOVENTUS COM CL A 09075A108 387,900 -115,275 -22.91 4,635 60.21 0.0070
2024-08-09 2024-06-30 13F BIOVENTUS COM CL A 09075A108 503,175 402,841 401.50 2,893 0.0049
2024-05-13 2024-03-31 13F BIOVENTUS COM CL A 09075A108 100,334 -34,911 -25.81 1 0.0008
2024-02-13 2023-12-31 13F BIOVENTUS COM CL A 09075A108 135,245 55,445 69.48 1 0.0011
2023-11-14 2023-09-30 13F BIOVENTUS COM CL A 09075A108 79,800 79,800 0 0.0004
2022-02-11 2021-12-31 13F BIOVENTUS COM CL A 09075A108 0 -23,900 -100.00 0 -100.00
2021-11-12 2021-09-30 13F BIOVENTUS COM CL A 09075A108 23,900 -62,100 -72.21 338 -77.68 0.0004
2021-08-13 2021-06-30 13F BIOVENTUS COM CL A 09075A108 86,000 86,000 1,514 0.0019
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.